Bio-Rad Labs (NYSE: BIO) reported Q1 EPS of $3.34, $0.46 worse than the analyst estimate of $3.80. Revenue for the quarter came in at $677 million versus the consensus estimate of $696.08 million.

For earnings history and earnings-related data on Bio-Rad Labs (BIO) click here.